Site icon InvestyWise

Biocon Issues Commercial Papers of ₹1,800 Crores

Biocon has announced the issuance of Commercial Papers (CP) amounting to ₹1,800 Crores on a private placement basis. The CPs have a tenure of 88 days, were allotted on December 22, 2025, and will mature on March 20, 2026. The coupon/interest rate offered is 6.85%. These CPs are proposed to be listed on the National Stock Exchange of India Limited and are issued in favor of several mutual funds.

Commercial Paper Issuance

Biocon has issued Commercial Papers (CP) worth ₹1,800 Crores through private placement.

Key Details of the CP Issue

Here’s a breakdown of the key terms and conditions:

Beneficiaries of the CP Issue

The Commercial Papers have been issued in favor of:

  1. SBI Mutual Fund – SBI Liquid Fund
  2. Axis Mutual Fund Trustee Ltd. A/c Axis Mutual Fund A/c Axis Liquid Fund
  3. Aditya Birla Sun Life Trustee Pvt Ltd A/c – Aditya Birla Sun Life Liquid Fund

Source: BSE

Exit mobile version